Reporter: Ritu Saxena, Ph.D.
An article published yesterday in Science Translational Medicine describes how mitochondrial deficits were rescued in the stem cells derived from Parkinson’s disease using pharmacological intervention.
The research published in the article has been discussed in the following news brief: http://www.worldpharmanews.com/research/2132-patient-derived-stem-cells-could-improve-drug-research-for-parkinsons
Research article: http://stm.sciencemag.org/content/4/141/141ra90.abstract
Great comment. I would like to see other posts on Mitochondrial dysfunction in other diseases and its pharmaco or other treatment options. Please check a category for this post: Resident based Cell therapy – it is on our list of categories. Thank you, Aviva
Thanks for your marvelous posting! I actually enjoyed reading it, you will be a great author.I will ensure that I bookmark your blog and will come back in the foreseeable future. I want to encourage that you continue your great job, have a nice weekend! think you’ve made some truly interesting points.
Ross Finesmith
Ms. Finesmith,
Thank you for your comment, The author will reply to your comment.
You can follow our website by e-mail, on the home page of the site on the lower right hand side of the page. Please follow us on twitter and the Group on LinkedIn called Leaders in Pharmaceutical Business Intelligence
Thanks Ross! I am glad you liked the post. I love writing and I love science, and I am getting the best of both worlds by contributing posts for this blog. I have written few more posts and if you click on my name, you should be able to read them. One of them is a whole review on mitochondrial diseases, research and current therapy options. Looking forward to more comments/suggestions from you. Thanks. Have a great weekend. Ritu
[…] http://pharmaceuticalintelligence.com/2012/07/05/stem-cells-for-the-rescue-of-mitochondrial-dysfunct… Share this:TwitterFacebookLinkedInStumbleUponLike this:Like3 bloggers like this. […]
[…] Stem cells for the rescue of mitochondrial dysfunction in Parkinson’s disease Reporter: Ritu Saxena, Ph.D. […]
I actually consider this amazing blog , âSAME SCIENTIFIC IMPACT: Scientific Publishing –
Open Journals vs. Subscription-based « Pharmaceutical Intelligenceâ, very compelling plus the blog post ended up being a good read.
Many thanks,Annette